![\"\"](\"https:\/\/www.europesays.com\/europe\/wp-content\/uploads\/2026\/05\/fkmrshe0z5s0.png\")
<\/p>\nMay 07, 2026
\nfrom CIRS
\nby CIRS<\/p>\n
On April 24\u00a02026, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued final\u00a0opinion (SCCS\/1685\/25)\u00a0on\u00a0Cannabidiol\u00a0(CBD) (CAS No. 13956-29- 1). Compared with the preliminary opinion released on November 19, 2025, the final version issued this time has been updated (all updated parts have been indicated in red).<\/p>\n
<\/p>\n
Final Opinion on CBD<\/p>\n
Based on the limited available data, the SCCS considers CBD safe when used at\u00a0concentrations up to 0.19% in dermal cosmetic products and oral cosmetic products-whether used separately or in combination.<\/p>\n
The SCCS considers the presence of THC impurities as safe at concentrations up to\u00a00.00025% in dermal and oral cosmetic products-whether used separately or in\u00a0combination.<\/p>\n
The SCCS acknowledges that the current evaluation may have some limitations because\u00a0of the paucity of data\/information received from a few respondents to the Commission\u2019s\u00a0Call for data. These limitations can be addressed as and when adequate data \/ information\u00a0can be made available by interested Applicants.<\/p>\n
This Scientific Advice does not consider the use of CBD in cosmetic products that may lead\u00a0to exposure of the end-user’s lungs by inhalation.<\/p>\n
Assessment Background<\/p>\n
Cannabidiol (CBD) is one of the approximately hundred naturally occurring cannabinoids found\u00a0in Cannabis plants and may account for up to 40 % of the plant’s extract. Cannabidiol (CBD) is\u00a0included in the\u00a0European\u00a0CosIng\u00a0with the\u00a0reported functions of skin conditioning, skin protecting, antioxidant, anti-sebum, etc.<\/p>\n
Currently, CBD as such is not regulated under Cosmetics\u00a0Regulation (EC) No 1223\/2009. However, entry 306 of Annex II to the Cosmetics Regulation\u00a0prohibits \u201cNarcotics, natural and synthetic: All substances listed in Tables I and II of the Single\u00a0Convention on narcotic drugs signed in New York on 30 March 1961\u201d\u00a0for use in cosmetic products.<\/p>\n
Considering the very limited available information regarding the safety of CBD in cosmetic\u00a0products, and to enable the SCCS to perform a safety assessment, a call for data\u00a0to collect\u00a0relevant scientific information was launched from 1 June 2023 to 30 September 2024. In view\u00a0of this, the Commission, requests the SCCS to assess the safety of CBD in cosmetic\u00a0products.<\/p>\n
Interpretation of CBD<\/p>\n
The Global Cosmetic Ingredient Regulatory Database-Global CosIng, independently developed by CIRS Group indicates that Cannabidiol (CBD, CAS No 13956-29-1) is included in the following key lists globally. In China, CBD is suspected to be listed the List of ingredients prohibited in cosmetic products.<\/p>\n
![\"\"](\"https:\/\/www.europesays.com\/europe\/wp-content\/uploads\/2026\/05\/fkmrw44l5og0.png\")
<\/p>\n
For more detailed information about Global CosIng or if you need any assistance or have any questions, please get in touch with us via cosmetic@cirs-group.com.<\/p>\n
Our ServicesEU Cosmetic Product Formula and Label ReviewEU Cosmetic Responsible PersonProduct Information File (PIF)EU Cosmetic Safety Assessment (CPSR)<\/p>\n
Further Information: We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.<\/p>\n","protected":false},"excerpt":{"rendered":"May 07, 2026 from CIRS by CIRS On April 24\u00a02026, the Scientific Committee on Consumer Safety (SCCS) of…\n","protected":false},"author":2,"featured_media":34053,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[22713,22714,22715,39,40,19094],"class_list":["post-34052","post","type-post","status-publish","format-standard","has-post-thumbnail","category-eu","tag-cannabidiol","tag-cbd-ingredient","tag-cosmetic","tag-eu","tag-european-union","tag-sccs"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts\/34052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/comments?post=34052"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/posts\/34052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/media\/34053"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/media?parent=34052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/categories?post=34052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/europe\/wp-json\/wp\/v2\/tags?post=34052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
SCCS-Final Opinion-CBD<\/a><\/p>\n![](\"https:\/\/www.europesays.com\/europe\/wp-content\/uploads\/2026\/04\/lQDPJxarRSbd_45rzQECsFoJ_qauLXzZAxms3q_AogA_258_107.jpg\")
<\/a>\u00a0\u00a0![](\"https:\/\/www.europesays.com\/europe\/wp-content\/uploads\/2026\/04\/lQDPJxarRSbd__FrzQECsPTc--u6lx-hAxms3q_AFAA_258_107.jpg\")
<\/a><\/p>\n